🔎 Trials Near Me

Akèy › Ipètansyon pulmonè › Alabama

Etid klinik pou Ipètansyon pulmonè nan Alabama

4 etid pou Ipètansyon pulmonè ap chèche patisipan nan sit nan Alabama.

Vil nan Alabama

Tèks ofisyèl etid la (Anglè)

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Alabama at Birmingham, Birmingham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

  • The University of Alabama at Birmingham, Birmingham
Ap rekriteVolontè an sante akeyi
1 Month – 5 Months · Tout sèks · Mizajou Aug 26, 2026 · NCT06373289

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

  • University of Alabama & Children's Hospital of Alabama (UAB-CoA), Birmingham
Ap rekriteFaz 4
0 Months – 1 Month · Tout sèks · Mizajou Aug 18, 2026 · NCT05213676

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.